Corbus Pharmaceuticals Holdings, Inc. (CRBP) insider trading

By person

14 insiders · 17 transactions

0.9×

Yuval Cohen holds only 0.9 times base salary in stock. $645.09K of shares against $646.57K in salary for 2025.

Salary from the company's own proxy. The shares are what Yuval Cohen last reported holding, valued at $4.10, the price Common Stock was last bought or sold at on the open market here, on 29 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Cormorant Asset Management, LP entity

Former 10% Owner

—

$2.09M (2)

−$2.09M

4,264,942

22.05%

$17.49M

−9.6%

Yuval Cohen

Chief Executive Officer

—

$279.35K (2) scheduled

−$279.35K

157,316

0.8134%

$645.09K

+103.7%

Sean F. Moran

Chief Financial Officer

—

$157.56K (2) scheduled

−$157.56K

84,694

0.4379%

$347.30K

+74.2%

Nishant C Saxena

Chief Business Officer

$126.25K (3)

—

+$126.25K

77,900

0.4028%

$319.44K

+2,126%

Dominic Smethurst

Chief Medical Officer

—

$77.18K (2)

−$77.18K

89,790

0.4642%

$368.19K

+79.6%

John Kenneth Jenkins

Director

—

$37.99K (1) scheduled

−$37.99K

3,833

0.0198%

$15.72K

+36.1%

Ian Hodgson

Chief Operating Officer

—

$25.79K (2)

−$25.79K

51,080

0.2641%

$209.46K

+96.6%

Anne Altmeyer

Director

—

$19.09K (1) scheduled

−$19.09K

7,579

0.0392%

$31.08K

+172.3%

Winston Kung

Director

—

$16.03K (1) scheduled

−$16.03K

12,140

0.0628%

$49.78K

+118.1%

Yong Ben

Director

—

$15.68K (1) scheduled

−$15.68K

9,383

0.0485%

$38.48K

+237.2%

Leonardo Viana Nicacio

Chief Medical Officer

—

58,333

0.3016%

$239.20K

—

Rachelle Suzanne Jacques

Director

—

11,383

0.0589%

$46.68K

+309.0%

Alan F Holmer

Director

—

10,629

0.0550%

$43.59K

+82.3%

Brent Pfeiffenberger

Director

—

7,500

0.0388%

$30.75K

—

Corbus Pharmaceuticals Holdings, Inc.

What the insiders did Net selling

By person